Trouble for Indian drug exporters continues with the Central Drugs Standard Control Organisation (CDSCO) investigating a complaint raised by Sri Lanka that eye drops made by a Gujarat-based firm are linked to eye infections in more than 30 people in the neighbouring country. Moreover, Indiana Ophthalmics, the Gujarat-based manufacturer, has now received a show-cause notice from the Pharmaceutical Exports Promotion Council (Pharmexcil). Its membership may be cancelled if it fails to respond by Saturday.
Indiana Ophthalmics is registered with the National Medicines Regulatory Authority of Sri Lanka and has been supplying prednisolone eye drops that are used to treat inflammation of the eyes caused by certain conditions for several years now. A source said the samples from the company have been sent for testing by CDSCO officials and it may take up to 10-15 days to get the reports on sterility etc.
In April Sri Lanka’s health
TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.
Subscribe To Insights
Key stories on business-standard.com are available to premium subscribers only.Already a BS Premium subscriber? Log in NOW
Or